Global and Japan PET Radiopharmaceuticals Market Insights, Forecast to 2026

Publisher Name :
Date: 27-Oct-2020
No. of pages: 126
Inquire Before Buying

PET Radiopharmaceuticals market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global PET Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the PET Radiopharmaceuticals market is segmented into

- F-18

- Ru-82

- Others

Segment by Application, the PET Radiopharmaceuticals market is segmented into

- Oncology

- Cardiology

- Neurology

- Others

Regional and Country-level Analysis

The PET Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).

The key regions covered in the PET Radiopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and PET Radiopharmaceuticals Market Share Analysis

PET Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in PET Radiopharmaceuticals business, the date to enter into the PET Radiopharmaceuticals market, PET Radiopharmaceuticals product introduction, recent developments, etc.

The major vendors covered:

- Cardinal Health Inc. (U.S.)

- Mallinckrodt plc (Ireland)

- GE Healthcare (U.K.)

- Lantheus Medical Imaging, Inc. (U.S.)

- Bayer AG (Germany)

- Bracco Imaging S.p.A (Italy)

- Eczacibasi-Monrol Nuclear Products (Turkey)

- Nordion, Inc. (Canada)

- Advanced Accelerator Applications S.A. (France)

- IBA Molecular Imaging (Belgium)

Global and Japan PET Radiopharmaceuticals Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 PET Radiopharmaceuticals Product Introduction
1.2 Market Segments
1.3 Key PET Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Type
1.4.2 F-18
1.4.3 Ru-82
1.4.4 Others
1.5 Market by Application
1.5.1 Global PET Radiopharmaceuticals Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Cardiology
1.5.4 Neurology
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global PET Radiopharmaceuticals Market Size, Estimates and Forecasts
2.1.1 Global PET Radiopharmaceuticals Revenue 2015-2026
2.1.2 Global PET Radiopharmaceuticals Sales 2015-2026
2.2 Global PET Radiopharmaceuticals, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 PET Radiopharmaceuticals Historical Market Size by Region (2015-2020)
2.3.1 Global PET Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global PET Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 PET Radiopharmaceuticals Market Estimates and Projections by Region (2021-2026)
2.4.1 Global PET Radiopharmaceuticals Sales Forecast by Region (2021-2026)
2.4.2 Global PET Radiopharmaceuticals Revenue Forecast by Region (2021-2026)
3 Global PET Radiopharmaceuticals Competitor Landscape by Players
3.1 Global Top PET Radiopharmaceuticals Sales by Manufacturers
3.1.1 Global PET Radiopharmaceuticals Sales by Manufacturers (2015-2020)
3.1.2 Global PET Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
3.2 Global PET Radiopharmaceuticals Manufacturers by Revenue
3.2.1 Global PET Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
3.2.2 Global PET Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
3.2.3 Global PET Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by PET Radiopharmaceuticals Revenue in 2019
3.2.5 Global PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global PET Radiopharmaceuticals Price by Manufacturers
3.4 Global PET Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 PET Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers PET Radiopharmaceuticals Product Type
3.4.3 Date of International Manufacturers Enter into PET Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global PET Radiopharmaceuticals Market Size by Type (2015-2020)
4.1.1 Global PET Radiopharmaceuticals Sales by Type (2015-2020)
4.1.2 Global PET Radiopharmaceuticals Revenue by Type (2015-2020)
4.1.3 PET Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
4.2 Global PET Radiopharmaceuticals Market Size Forecast by Type (2021-2026)
4.2.1 Global PET Radiopharmaceuticals Sales Forecast by Type (2021-2026)
4.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
4.2.3 PET Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global PET Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global PET Radiopharmaceuticals Market Size by Application (2015-2020)
5.1.1 Global PET Radiopharmaceuticals Sales by Application (2015-2020)
5.1.2 Global PET Radiopharmaceuticals Revenue by Application (2015-2020)
5.1.3 PET Radiopharmaceuticals Price by Application (2015-2020)
5.2 PET Radiopharmaceuticals Market Size Forecast by Application (2021-2026)
5.2.1 Global PET Radiopharmaceuticals Sales Forecast by Application (2021-2026)
5.2.2 Global PET Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
5.2.3 Global PET Radiopharmaceuticals Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan PET Radiopharmaceuticals Market Size YoY Growth 2015-2026
6.1.1 Japan PET Radiopharmaceuticals Sales YoY Growth 2015-2026
6.1.2 Japan PET Radiopharmaceuticals Revenue YoY Growth 2015-2026
6.1.3 Japan PET Radiopharmaceuticals Market Share in Global Market 2015-2026
6.2 Japan PET Radiopharmaceuticals Market Size by Players (International and Local Players)
6.2.1 Japan Top PET Radiopharmaceuticals Players by Sales (2015-2020)
6.2.2 Japan Top PET Radiopharmaceuticals Players by Revenue (2015-2020)
6.3 Japan PET Radiopharmaceuticals Historic Market Review by Type (2015-2020)
6.3.1 Japan PET Radiopharmaceuticals Sales Market Share by Type (2015-2020)
6.3.2 Japan PET Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
6.3.3 Japan PET Radiopharmaceuticals Price by Type (2015-2020)
6.4 Japan PET Radiopharmaceuticals Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan PET Radiopharmaceuticals Sales Forecast by Type (2021-2026)
6.4.2 Japan PET Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
6.4.3 Japan PET Radiopharmaceuticals Price Forecast by Type (2021-2026)
6.5 Japan PET Radiopharmaceuticals Historic Market Review by Application (2015-2020)
6.5.1 Japan PET Radiopharmaceuticals Sales Market Share by Application (2015-2020)
6.5.2 Japan PET Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
6.5.3 Japan PET Radiopharmaceuticals Price by Application (2015-2020)
6.6 Japan PET Radiopharmaceuticals Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan PET Radiopharmaceuticals Sales Forecast by Application (2021-2026)
6.6.2 Japan PET Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
6.6.3 Japan PET Radiopharmaceuticals Price Forecast by Application (2021-2026)
7 North America
7.1 North America PET Radiopharmaceuticals Market Size YoY Growth 2015-2026
7.2 North America PET Radiopharmaceuticals Market Facts & Figures by Country
7.2.1 North America PET Radiopharmaceuticals Sales by Country (2015-2020)
7.2.2 North America PET Radiopharmaceuticals Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe PET Radiopharmaceuticals Market Size YoY Growth 2015-2026
8.2 Europe PET Radiopharmaceuticals Market Facts & Figures by Country
8.2.1 Europe PET Radiopharmaceuticals Sales by Country
8.2.2 Europe PET Radiopharmaceuticals Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific PET Radiopharmaceuticals Market Size YoY Growth 2015-2026
9.2 Asia Pacific PET Radiopharmaceuticals Market Facts & Figures by Country
9.2.1 Asia Pacific PET Radiopharmaceuticals Sales by Region (2015-2020)
9.2.2 Asia Pacific PET Radiopharmaceuticals Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America PET Radiopharmaceuticals Market Size YoY Growth 2015-2026
10.2 Latin America PET Radiopharmaceuticals Market Facts & Figures by Country
10.2.1 Latin America PET Radiopharmaceuticals Sales by Country
10.2.2 Latin America PET Radiopharmaceuticals Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa PET Radiopharmaceuticals Market Size YoY Growth 2015-2026
11.2 Middle East and Africa PET Radiopharmaceuticals Market Facts & Figures by Country
11.2.1 Middle East and Africa PET Radiopharmaceuticals Sales by Country
11.2.2 Middle East and Africa PET Radiopharmaceuticals Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Cardinal Health Inc. (U.S.)
12.1.1 Cardinal Health Inc. (U.S.) Corporation Information
12.1.2 Cardinal Health Inc. (U.S.) Description and Business Overview
12.1.3 Cardinal Health Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Products Offered
12.1.5 Cardinal Health Inc. (U.S.) Recent Development
12.2 Mallinckrodt plc (Ireland)
12.2.1 Mallinckrodt plc (Ireland) Corporation Information
12.2.2 Mallinckrodt plc (Ireland) Description and Business Overview
12.2.3 Mallinckrodt plc (Ireland) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Products Offered
12.2.5 Mallinckrodt plc (Ireland) Recent Development
12.3 GE Healthcare (U.K.)
12.3.1 GE Healthcare (U.K.) Corporation Information
12.3.2 GE Healthcare (U.K.) Description and Business Overview
12.3.3 GE Healthcare (U.K.) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GE Healthcare (U.K.) PET Radiopharmaceuticals Products Offered
12.3.5 GE Healthcare (U.K.) Recent Development
12.4 Lantheus Medical Imaging, Inc. (U.S.)
12.4.1 Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
12.4.2 Lantheus Medical Imaging, Inc. (U.S.) Description and Business Overview
12.4.3 Lantheus Medical Imaging, Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Products Offered
12.4.5 Lantheus Medical Imaging, Inc. (U.S.) Recent Development
12.5 Bayer AG (Germany)
12.5.1 Bayer AG (Germany) Corporation Information
12.5.2 Bayer AG (Germany) Description and Business Overview
12.5.3 Bayer AG (Germany) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Bayer AG (Germany) PET Radiopharmaceuticals Products Offered
12.5.5 Bayer AG (Germany) Recent Development
12.6 Bracco Imaging S.p.A (Italy)
12.6.1 Bracco Imaging S.p.A (Italy) Corporation Information
12.6.2 Bracco Imaging S.p.A (Italy) Description and Business Overview
12.6.3 Bracco Imaging S.p.A (Italy) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Products Offered
12.6.5 Bracco Imaging S.p.A (Italy) Recent Development
12.7 Eczacibasi-Monrol Nuclear Products (Turkey)
12.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
12.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) Description and Business Overview
12.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Products Offered
12.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Recent Development
12.8 Nordion, Inc. (Canada)
12.8.1 Nordion, Inc. (Canada) Corporation Information
12.8.2 Nordion, Inc. (Canada) Description and Business Overview
12.8.3 Nordion, Inc. (Canada) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Nordion, Inc. (Canada) PET Radiopharmaceuticals Products Offered
12.8.5 Nordion, Inc. (Canada) Recent Development
12.9 Advanced Accelerator Applications S.A. (France)
12.9.1 Advanced Accelerator Applications S.A. (France) Corporation Information
12.9.2 Advanced Accelerator Applications S.A. (France) Description and Business Overview
12.9.3 Advanced Accelerator Applications S.A. (France) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Products Offered
12.9.5 Advanced Accelerator Applications S.A. (France) Recent Development
12.10 IBA Molecular Imaging (Belgium)
12.10.1 IBA Molecular Imaging (Belgium) Corporation Information
12.10.2 IBA Molecular Imaging (Belgium) Description and Business Overview
12.10.3 IBA Molecular Imaging (Belgium) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Products Offered
12.10.5 IBA Molecular Imaging (Belgium) Recent Development
12.11 Cardinal Health Inc. (U.S.)
12.11.1 Cardinal Health Inc. (U.S.) Corporation Information
12.11.2 Cardinal Health Inc. (U.S.) Description and Business Overview
12.11.3 Cardinal Health Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Products Offered
12.11.5 Cardinal Health Inc. (U.S.) Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key PET Radiopharmaceuticals Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 PET Radiopharmaceuticals Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. PET Radiopharmaceuticals Market Segments
Table 2. Ranking of Global Top PET Radiopharmaceuticals Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global PET Radiopharmaceuticals Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of F-18
Table 5. Major Manufacturers of Ru-82
Table 6. Major Manufacturers of Others
Table 7. Global PET Radiopharmaceuticals Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 8. Global PET Radiopharmaceuticals Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 9. Global PET Radiopharmaceuticals Sales by Regions 2015-2020 (K Pcs)
Table 10. Global PET Radiopharmaceuticals Sales Market Share by Regions (2015-2020)
Table 11. Global PET Radiopharmaceuticals Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global PET Radiopharmaceuticals Sales Forecast by Region (2021-2026) (K Pcs)
Table 13. Global PET Radiopharmaceuticals Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global PET Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 15. Global PET Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global PET Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PET Radiopharmaceuticals as of 2019)
Table 17. PET Radiopharmaceuticals Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. PET Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers PET Radiopharmaceuticals Price (2015-2020) (USD/Pcs)
Table 20. PET Radiopharmaceuticals Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers PET Radiopharmaceuticals Product Type
Table 22. Date of International Manufacturers Enter into PET Radiopharmaceuticals Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global PET Radiopharmaceuticals Sales by Type (2015-2020) (K Pcs)
Table 25. Global PET Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 26. Global PET Radiopharmaceuticals Revenue by Type (2015-2020) (US$ Million)
Table 27. Global PET Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 28. PET Radiopharmaceuticals Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global PET Radiopharmaceuticals Sales Share by Type (2021-2026)
Table 30. Global PET Radiopharmaceuticals Sales by Application (2015-2020) (K Pcs)
Table 31. Global PET Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 32. Global PET Radiopharmaceuticals Sales Share by Application (2021-2026)
Table 33. Global PET Radiopharmaceuticals Sales Market Share Forecast by Application (2021-2026)
Table 34. Global PET Radiopharmaceuticals Revenue by Application (2015-2020) (US$ Million)
Table 35. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Application (2021-2026)
Table 36. Japan PET Radiopharmaceuticals Sales (K Pcs) of Key Companies (2015-2020)
Table 37. Japan PET Radiopharmaceuticals Sales Share by Company (2015-2020)
Table 38. Japan PET Radiopharmaceuticals Revenue (US$ Million) by Company (2015-2020)
Table 39. Japan PET Radiopharmaceuticals Sales (K Pcs) by Type (2015-2020)
Table 40. Japan PET Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 41. Japan PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2015-2020)
Table 42. Japan PET Radiopharmaceuticals Price (K Pcs) by Type (2015-2020)
Table 43. Japan PET Radiopharmaceuticals Sales (K Pcs) by Type (2021-2026)
Table 44. Japan PET Radiopharmaceuticals Sales Share by Type (2021-2026)
Table 45. Japan PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Type (2021-2026)
Table 46. Japan PET Radiopharmaceuticals Revenue Share by Type (2021-2026)
Table 47. Japan PET Radiopharmaceuticals Price (K Pcs) by Type (2021-2026)
Table 48. Japan PET Radiopharmaceuticals Sales (K Pcs) by Application (2015-2020)
Table 49. Japan PET Radiopharmaceuticals Sales Share by Application (2015-2020)
Table 50. Japan PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2015-2020)
Table 51. Japan PET Radiopharmaceuticals Sales (K Pcs) by Application (2021-2026)
Table 52. Japan PET Radiopharmaceuticals Sales Share by Application (2021-2026)
Table 53. Japan PET Radiopharmaceuticals Revenue (US$ Million) Market Share by Application (2021-2026)
Table 54. Japan PET Radiopharmaceuticals Revenue Share by Application (2021-2026)
Table 55. North America PET Radiopharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 56. North America PET Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 57. North America PET Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 58. North America PET Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 59. Europe PET Radiopharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 60. Europe PET Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 61. Europe PET Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 62. Europe PET Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 63. Asia Pacific PET Radiopharmaceuticals Sales by Region (2015-2020) (K Pcs)
Table 64. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 65. Asia Pacific PET Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 66. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 67. Latin America PET Radiopharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 68. Latin America PET Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 69. Latin Americaa PET Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 70. Latin America PET Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa PET Radiopharmaceuticals Sales by Country (2015-2020) (K Pcs)
Table 72. Middle East and Africa PET Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 73. Middle East and Africa PET Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 74. Middle East and Africa PET Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 75. Cardinal Health Inc. (U.S.) Corporation Information
Table 76. Cardinal Health Inc. (U.S.) Description and Business Overview
Table 77. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product
Table 79. Cardinal Health Inc. (U.S.) Recent Development
Table 80. Mallinckrodt plc (Ireland) Corporation Information
Table 81. Mallinckrodt plc (Ireland) Description and Business Overview
Table 82. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Mallinckrodt plc (Ireland) Product
Table 84. Mallinckrodt plc (Ireland) Recent Development
Table 85. GE Healthcare (U.K.) Corporation Information
Table 86. GE Healthcare (U.K.) Description and Business Overview
Table 87. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. GE Healthcare (U.K.) Product
Table 89. GE Healthcare (U.K.) Recent Development
Table 90. Lantheus Medical Imaging, Inc. (U.S.) Corporation Information
Table 91. Lantheus Medical Imaging, Inc. (U.S.) Description and Business Overview
Table 92. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Lantheus Medical Imaging, Inc. (U.S.) Product
Table 94. Lantheus Medical Imaging, Inc. (U.S.) Recent Development
Table 95. Bayer AG (Germany) Corporation Information
Table 96. Bayer AG (Germany) Description and Business Overview
Table 97. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Bayer AG (Germany) Product
Table 99. Bayer AG (Germany) Recent Development
Table 100. Bracco Imaging S.p.A (Italy) Corporation Information
Table 101. Bracco Imaging S.p.A (Italy) Description and Business Overview
Table 102. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Bracco Imaging S.p.A (Italy) Product
Table 104. Bracco Imaging S.p.A (Italy) Recent Development
Table 105. Eczacibasi-Monrol Nuclear Products (Turkey) Corporation Information
Table 106. Eczacibasi-Monrol Nuclear Products (Turkey) Description and Business Overview
Table 107. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. Eczacibasi-Monrol Nuclear Products (Turkey) Product
Table 109. Eczacibasi-Monrol Nuclear Products (Turkey) Recent Development
Table 110. Nordion, Inc. (Canada) Corporation Information
Table 111. Nordion, Inc. (Canada) Description and Business Overview
Table 112. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 113. Nordion, Inc. (Canada) Product
Table 114. Nordion, Inc. (Canada) Recent Development
Table 115. Advanced Accelerator Applications S.A. (France) Corporation Information
Table 116. Advanced Accelerator Applications S.A. (France) Description and Business Overview
Table 117. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 118. Advanced Accelerator Applications S.A. (France) Product
Table 119. Advanced Accelerator Applications S.A. (France) Recent Development
Table 120. IBA Molecular Imaging (Belgium) Corporation Information
Table 121. IBA Molecular Imaging (Belgium) Description and Business Overview
Table 122. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. IBA Molecular Imaging (Belgium) Product
Table 124. IBA Molecular Imaging (Belgium) Recent Development
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key PET Radiopharmaceuticals Players
Table 129. PET Radiopharmaceuticals Customers List
Table 130. PET Radiopharmaceuticals Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. PET Radiopharmaceuticals Product Picture
Figure 2. Global PET Radiopharmaceuticals Sales Market Share by Type in 2020 & 2026
Figure 3. F-18 Product Picture
Figure 4. Ru-82 Product Picture
Figure 5. Others Product Picture
Figure 6. Global PET Radiopharmaceuticals Sales Market Share by Application in 2020 & 2026
Figure 7. Oncology
Figure 8. Cardiology
Figure 9. Neurology
Figure 10. Others
Figure 11. PET Radiopharmaceuticals Report Years Considered
Figure 12. Global PET Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 13. Global PET Radiopharmaceuticals Sales 2015-2026 (K Pcs)
Figure 14. Global PET Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global PET Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 16. Global PET Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 17. Global PET Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 18. Global PET Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 19. Global PET Radiopharmaceuticals Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by PET Radiopharmaceuticals Revenue in 2019
Figure 21. PET Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global PET Radiopharmaceuticals Sales Market Share by Type (2015-2020)
Figure 23. Global PET Radiopharmaceuticals Sales Market Share by Type in 2019
Figure 24. Global PET Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
Figure 25. Global PET Radiopharmaceuticals Revenue Market Share by Type in 2019
Figure 26. Global PET Radiopharmaceuticals Market Share by Price Range (2015-2020)
Figure 27. Global PET Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 28. Global PET Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 29. Global PET Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
Figure 30. Global PET Radiopharmaceuticals Revenue Market Share by Application in 2019
Figure 31. Japan PET Radiopharmaceuticals Sales Growth Rate 2015-2026 (K Pcs)
Figure 32. Japan PET Radiopharmaceuticals Revenue Growth Rate 2015-2026 (US$ Million)
Figure 33. Japan PET Radiopharmaceuticals Market Share in Global Market 2015-2026
Figure 34. Japan 5 and 10 Largest PET Radiopharmaceuticals Players Market Share by Revenue in PET Radiopharmaceuticals in 2019
Figure 35. Japan PET Radiopharmaceuticals Revenue Share by Type (2015-2020)
Figure 36. Japan PET Radiopharmaceuticals Revenue Growth Rate by Type in 2015 & 2019
Figure 37. Japan PET Radiopharmaceuticals Revenue Share by Application (2015-2020)
Figure 38. Japan PET Radiopharmaceuticals Revenue Growth Rate by Application in 2015 & 2019
Figure 39. North America PET Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. North America PET Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. North America PET Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 42. North America PET Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 43. U.S. PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. U.S. PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Canada PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Canada PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Europe PET Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 48. Europe PET Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 49. Europe PET Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 50. Europe PET Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 51. Germany PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Germany PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. France PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. France PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. U.K. PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. U.K. PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Italy PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Italy PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Russia PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Asia Pacific PET Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific PET Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific PET Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 64. Asia Pacific PET Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 65. China PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Latin America PET Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America PET Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America PET Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 90. Latin America PET Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 91. Mexico PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina PET Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina PET Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Middle East and Africa PET Radiopharmaceuticals Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa PET Radiopharmaceuticals Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa PET Radiopharmaceuticals Sales Market Share b
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs